Please note: AABB reserves the right to make updates to this program.
Live Program Date: Thursday, February 2, 2023 - On-Demand Available
Program Number: 23EL-804
This on-demand hot topic discussion is complimentary to all but registration is required. After signing up on GoToWebinar, the video will immediately begin to play.
Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER), will discuss the FDA’s Jan. 27 draft guidance, "Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products” and its implications for the blood community.
Following Marks’ presentation, Sharon Carayiannis, MT(ASCP)HP, vice president of science and practice at AABB, will moderate a question-and-answer session.
Continuing education credit will not be offered for this program.